0001062993-23-022931.txt : 20231220 0001062993-23-022931.hdr.sgml : 20231220 20231220151837 ACCESSION NUMBER: 0001062993-23-022931 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 EFFECTIVENESS DATE: 20231220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Thiogenesis Therapeutics, Corp. CENTRAL INDEX KEY: 0001877778 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500297 FILM NUMBER: 231501204 BUSINESS ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 BUSINESS PHONE: 6478467766 MAIL ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 FORMER COMPANY: FORMER CONFORMED NAME: Rozdil Capital Corp DATE OF NAME CHANGE: 20210810 D 1 primary_doc.xml X0708 D LIVE 0001877778 Thiogenesis Therapeutics, Corp. 4 KING STREET WEST, SUITE 401 TORONTO A6 ONTARIO, CANADA M5H 1B6 (888) 223-9165 ONTARIO, CANADA Rozdil Capital Corp Corporation true 2018 Brook G. Riggins 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director Patrice Rioux 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director W. Hogan Mullally 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Kim Tsuchimoto 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Christopher Starr 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Other Decline to Disclose 06b false 2023-12-15 false true false 0 252281 252281 0 U.S. dollar amount is based on the Bank of Canada exchange rate 0.7475 reported on December 15, 2023. false 1 0 0 0 false Thiogenesis Therapeutics, Corp. /s/ Brook G. Riggins Brook G. Riggins CFO 2023-12-20